PR
Prothena
PRTA·NASDAQDublin IEFounded 2012400 employees
Mid CapbiotechPublicNeurology
Platform: Anti-TDP43
Market Cap
$4B
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (PRTA)
Loading PRTA stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PRT-8732 | PRT-8732 | Phase 2/3 | 1 | PLK4 | MMFL | ||
| Semarasimod | PRT-1199 | Phase 1/2 | 1 | Cl18.2 | PBC | ||
| Bemaglumide | PRT-7529 | Phase 3 | 2 | MDM2 | Prostate Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)